Dishman Pharmaceuticals & Chemicals (Delisted) share news and announcements

BSE: 532526

Last traded ₹301.20 on 29 May 2017

Delisted on 8 Jan 2018.

Dishman Pharmaceuticals & Chemicals share news and announcements

747 announcements, routine notices left out, newest first. Page 6 of 15.

Aug 2015
- 22 Aug · Dividend
  Board of Directors of the Company at its meeting held on August 22, 2015, inter alia, has taken the following decisions: ....
- 21 Aug · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 14 Aug · Board meeting
  Meeting of the Board of Directors of the Company will be held on August 22, 2015, inter alia, to consider and take on record ....
- 14 Aug · Meeting
  Extra Ordinary General Meeting (EGM) of the Company held on August 14, 2015, under Clause 35A. (opens in a new tab)
- 14 Aug · Disclosure of Voting Pattern - Clause 35A
  Outcome of Extra Ordinary General Meeting and Details of voting as per Clause 35A of the Listing Agreement along with copy of Scrutinizer's Report. (opens in a new tab)
- 14 Aug · Board meeting
  To consider and take on record, inter alia, the Audited Financial Results of the Company for the year ended March 31, 2015 and to recommend Final Dividend, if any. (opens in a new tab)
Jul 2015
- 20 Jul · Updates
  E-voting facility for the Extra Ordinary General Meeting to be held on August 14, 2015, is availabe from August 11, 2015 to August 13, 2015. (opens in a new tab)
- 20 Jul · Meeting
  An Extra-ordinary General Meeting (EGM) of the Company will be held on August 14, 2015. (opens in a new tab)
- 20 Jul · Meeting
  Copy of Notice of Extra Ordinary General Meeting to be held on August 14, 2015. (opens in a new tab)
- 18 Jul · Board meeting
  At the Board Meeting held on July 17, 2015, the board has deffered the agenda pertaining to Approval of Audited Annual Accounts, consequently, the decision of declaration of Dividend has also been deffered. (opens in a new tab)
- 18 Jul · Board meeting
  Meeting of the Board of Directors of the Company was held on July 17, 2015, at the said Board Meeting the Board has deferred ....
- 18 Jul · Board meeting
  Outcome of the Board Meeting held on July 17, 2015. (opens in a new tab)
- 18 Jul · Board meeting
  Board of Directors of the Company at its meeting held on July 17, 2015, inter alia, has taken following decisions: .... (opens in a new tab)
- 14 Jul · Shareholding Pattern For June 30, 2015
  Shareholding Pattern as on June 30, 2015. (opens in a new tab)
- 11 Jul · Board meeting
  To consider and take on record, inter alia, the Audited Financial Results of the Company for the year ended March 31, 2015 and to recommend Final Dividend, if any. (opens in a new tab)
- 11 Jul · Board meeting
  Meeting of the Board of Directors of the Company will be held on July 17, 2015, inter alia, to consider and take on record ....
- 6 Jul · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Jun 2015
May 2015
- 28 May · Board Meeting Deferred
  Board has deferred the Agenda relating to approval of the Audited financial statements for the year ended March 31, 2015 in view of disagreement with the statutory auditors with regard to reporting in the consolidated financial statements regarding accounting of employee pension benefits by the Swiss subsidiary CARBOGEN AMCIS, which is covering this liability by participating in an employee retirement benefit plan of a large and well respected insurance company. As per Swiss GAAP, the said subsidiary has no liability for the same. However, the accounting treatment as per Indian GAAP is creating a technical anomaly and being material, the Board has felt it prudent to defer this Agenda item so that the matter can be appropriately addressed. Consequently the agenda items relating to recommendation of dividend and other items related to audited financial result have also been deferred. (opens in a new tab)
- 28 May · Board meeting
  Board of Directors of the Company at its meeting held on May 28, 2015, has transacted the following:- "1. The ....
- 28 May · Results
  Standalone & consolidated financial results for the period ended 31-Mar-2015. (opens in a new tab)
- 28 May · Results
  UnAudited Financial Results for the period ended March 31, 2015. (opens in a new tab)
- 28 May · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 25 May · Board rescheduled on May 28, 2015
  Due to unavoidable circumstances, the Meeting of Board of Directors of Company which was scheduled to be held on May 25, ....
- 25 May · Board meeting
  Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held on May 25, 2015 ,To consider and take on record, inter alia, the Audited Financial Results of the Company for the year ended March 31, 2015, to recommend Final Dividend, if any. The Company has now informed the Exchange that the meeting of the Board of Directors has now been postponed to May 28, 2015 (Revised). (opens in a new tab)
- 20 May · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 15 May · Code of Conduct of Fair Disclosure
  Pursuant to the SEBI (Prohibition of Insider Trading) Regulation, 2015 and SEBI Circular dated May 11, 2015, the Company .... (opens in a new tab)
- 15 May · Code of Conduct under SEBI(PIT) Reg., 2015
  Pursuant to the SEBI (Prohibition of Insider Trading) Regulation, 2015 and SEBI Circular bearing No.CIR/ISD/01/2015 dated 11th May, 2015, the Company has formulated a Code of Conduct for Prevention of Insider Trading. The same has also been disseminated to the employees of the Company for their information and compliance. Enclosed is Code of Practices and Procedure for fair disclosure adopted by the Company. (opens in a new tab)
- 4 May · Board meeting
  To consider and take on record, inter alia, the Audited Financial Results of the Company for the year ended March 31, 2015, to recommend Final Dividend, if any. (opens in a new tab)
- 4 May · Board meeting
  Meeting of the Board of Directors of the Company will be held on May 25, 2015, inter alia, to consider and take on record, ....
Apr 2015
- 10 Apr · Shareholding Pattern For March 31, 2015
  Shareholding Pattern as on March 31, 2015. (opens in a new tab)
- 8 Apr · Disclosure
  Janmejay R. Vyas has informed the Exchange that has submitted to the Exchange vide letter dated April 08, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 6 Apr · Disclosure
  Dishman Pharmaceuticals and Chemicals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 6 Apr · Management
  Board of Directors vide circular resolution dated April 2, 2015, have approved the appointment of Mr. Rajendra S. Shah as an Additional Director of the Company, Mr. Rajendra S. Shah shall hold office as an Additional Director w.e.f. April 2, 2015 till the ensuing Annual General Meeting of the Company. The Board has considered him as an Independent Director in terms of the provisions of the Companies Act, 2013 and Listing Agreement. (opens in a new tab)
- 3 Apr · Management
  Board of Directors vide circular resolution dated April 02, 2015, have approved the appointment of Mr. Rajendra S. Shah ....
Mar 2015
- 23 Mar · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 17 Mar · Disclosure
  Arpit J Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Feb 2015
- 13 Feb · Limited Review for Dec 31, 2014
  Limited Review Report for the period ended December 31, 2014. (opens in a new tab)
- 13 Feb · Results
  Financial Results for the period ended December 31, 2014. (opens in a new tab)
- 13 Feb · Results
  Standalone & consolidated financial results for the period ended 31-Dec-2014. (opens in a new tab)
- 2 Feb · Board meeting
  Inter alia, to consider and take on record the Unaudited Financial Results (Provisional) of the Company for the quarter ended December 31, 2014.
Jan 2015